5th International Conference on Heart and Cardiovascular Diseases

Hypertension affects 1.28 billion adults worldwide and remains the single largest modifiable cardiovascular risk factor, yet global blood pressure control rates remain below 25%. The Hypertension session examines the renal denervation resurgence following SPYRAL and RADIANCE sham-controlled trials, the new drug class of aldosterone synthase inhibitors (lorundrostat, baxdrostat) in resistant hypertension, zilebesiran, an RNA interference antihypertensive agent showing sustained BP reduction from twice-yearly dosing ambulatory BP monitoring in diagnosis, LVH regression strategies in hypertensive heart disease, and the distinct management challenges of hypertension in pregnancy and preeclampsia.

Key Discussion Areas:

• Contemporary approaches to diagnosing and managing hypertension in daily clinical practice
• Integrating hypertension management within general cardiology care
• Translating guideline updates into practical clinical decisions
• Managing hypertension alongside common comorbidities such as diabetes, obesity, and chronic kidney disease
• Patient adherence and long-term blood pressure control challenges
• Emerging clinical tools and risk calculators for everyday practice

Sub Tracks

• General & Clinical Cardiology Practice
• Blood Pressure Management & Monitoring
• Hypertension Diagnosis & Classification
• Guideline-Directed Hypertension Management
• Hypertension with Comorbid Conditions
• Patient Adherence & Long-Term BP Control
• Clinical Case Studies & Practice-Based Research
• Internal Medicine & Multisystem Cardiovascular Care
• Emergency & Acute Cardiovascular Care
• Case Reports & Challenging Clinical Cases
• Cardiac Nursing & Patient-Centered Care
• Cardio-renal Medicine
• Cardio-Oncology

Why Attend This Session?

General cardiologists, internists, and primary care physicians will find practical, guideline-aligned updates they can apply directly in daily patient care, along with a platform to share case-based research and real-world clinical experience in hypertension management.

Related Topics:

Cardiorenal Medicine | Preventive Cardiology | Cardiometabolic & Lipidology | Coronary & Ischemic Heart Disease

Frequently Asked Questions:

Q: Who should attend this track?

A: General cardiologists, internists, and primary care physicians managing hypertension as part of routine cardiology care.

Q: Does this track cover guideline updates?

A: Yes, translating current hypertension guidelines into practical clinical decisions is a core discussion area.

Q: Is this track relevant to primary care physicians?

A: Yes, the content is framed around practical, everyday clinical decision-making applicable to primary care settings.

Q: Does the track include case-based research?

A: Yes, clinical case studies and practice-based research are a dedicated sub-track.